CML and Environmental Factors Related to Complex Karyotypes.

Blood ◽  
2004 ◽  
Vol 104 (11) ◽  
pp. 4654-4654
Author(s):  
Valle Recasens ◽  
Araceli Rubio-Martinez ◽  
Maria Odero ◽  
Maria Jose Calasanz ◽  
Luis Palomera ◽  
...  

Abstract Background: Chronic myeloid leukemia (CML) is a clonal disorder of abnormal pluriopotent stem cell characterized by the translocation t(9;22)(q34;q11) that results in a BCR/ABL fusion gene called Philadelphia (Ph) chromosome. Other complex Ph abnormalities or unusual cytogenetic rearrangements have been described and are considered by some researchers to be unfavourable prognosis factors. Aims: To perform a epidemiological study to consider environmental exposures in patients diagnosed of CML in a northern Spanish area (Aragon) and to evaluate differences among CML patients regarding complex or variant karyotypes versus classic t(9;22)(q34;q11). Patients and methods: Observational, descriptive and retrospective-prospective study. Data resources: medical records and data from haematological registry of the Aragon Community. A structured telephone survey was used to evaluate the exposure. Variables: age, gender, date and place of birth, place of residence, date of diagnosis, Kantarjian score system, cytogenetic characteristics as standard Ph’ or variant translocation, type of therapy, status of disease at the time of study, time to progression and occupational and leisure exposures to toxic products, regular personal use of hair dye, participation in wars, lifestyle, animals, dietary habits, cellular phone use, cigarette smoking, alcoholic beverage and specific recreational drug intake, medical history focused on chemotherapy, radiation therapy, and treatment with isotopes, hepatitis B virus (HBV), hepatitis C virus (HCV), Epstein-Barr virus (EBV), Zoster Herpes virus (ZHV) and cytomegalovirus (CMV) infection, and personal and familial history of neoplastic disorders. The study was based on a cohort of 67 patients in diagnosed as having CML in chronic phase between 1999–2003. All cytogenetic analysis were performed in the same laboratory and included: standard cytogenetic analysis, fluorescence in situ hybridization using a BCR/ABL specific probe and molecular study by qualitative PCR. Data were introduced into SPSS statistical package 11.0 to perform descriptive statistical, risk analysis and non-parametric tests in order to evaluate differences between classic and complex or variant karyotypes. Results: 34 males (50.7%) and 33 females (49.3%) were included in the study but only 60 were available to analyze. Mean age 52, range 19–86. Variant or complex kariotypes 14 (23.3%): males 11(78.5%), females 3(21.5%). Typical or classical t(9;22)(q34;q11) 46 (76.7%): males 24 (52.2%), females 22 (47.8%). No statistical differences were found between both groups except for smoking habit. A major number of complex or variant karyotypes was showed in current cigarette smokers with a statistical significance (p=0.004). Most of the subjects with classic translocation reported having pets, mainly dogs (p=0,038). All the subjects with a previous contact with toxic product belong to the group of classical karyotype. These different toxics emerging from the interviews were cobalt, lead, oil-based paints, petrol-derived chemical products, etchings, sulphates, varnishes, glue, PVC, solvents pesticides and benzene. Conclusion: A remarkable incidence of complex or variant kariotypes have been found in our area: 23.3%. These complex or variant kariotypes were found mainly in men. Smokers showed a higher incidence of variant or complex kariotypes.

Blood ◽  
2004 ◽  
Vol 104 (11) ◽  
pp. 2942-2942
Author(s):  
Samar Issa ◽  
Duncan Holdsworth ◽  
Paul Oei ◽  
Peter J. Browett

Abstract The hallmark of CML is the BCR/ABL fusion gene that is usually formed as a result of the t(9;22) translocation. Conventional cytogenetic analysis has been the standard method for monitoring the Philadelphia (Ph) chromosome, however evaluation of the BCR/ABL fusion gene using interphase Fluorescence in situHybridisation (FISH) on peripheral blood may allow more frequent and less invasive follow up of CML patients. The objective of this study was to compare the utility of peripheral blood FISH versus bone marrow FISH and conventional cytogenetics in patients with CML following treatment with Imatinib mesylate. 61 sets of peripheral blood and bone marrow aspirate samples from 33 Ph positive chronic phase CML patients receiving treatment with Imatinib mesylate were assessed from December 2002 to February 2004. Bone marrow samples were processed by standard cytogenetic procedures and G-banded analysis of at least 20 metaphases per sample was performed. Interphase FISH on non selected peripheral blood and bone marrow samples was carried out by scoring positive signals in 600 nuclei in each sample using BCR/ABL dual fusion or extra signal probes (Vysis). Bland and Altman plots were constructed to assess the level of agreement between the tests and the mean differences (with 95% confidence intervals) were determined. 13 of the 33 patients studied were male and 21 (64%) of the patients were analyzed at more than one timepoint. Although there was good agreement of peripheral blood FISH with bone marrow FISH and bone marrow cytogenetics in monitoring changes in the level of Ph positive cells following therapy, there were statistically significant differences in the agreement between the percentage levels of BCR/ABL positive cells between bone marrow cytogenetics and bone marrow and peripheral blood FISH. Cytogenetic analysis revealed significantly higher levels of BCR/ABL positive cells when compared to both peripheral blood FISH [9% (95% CI 4.6, 14.1), p=0.013] and bone marrow FISH [5% (95% CI 1.7, 7.8, p=0.013)]. The mean difference in the percentages of the Ph positive cells measured by bone marrow FISH exceeded the peripheral blood FISH by 5% (95% CI 1.0, 8.1, p=0.037). There was a significant relationship between the differences observed and the actual percentage level of BCR/ABL positive cells (P<0.001) with most of the discrepancy being driven by tests with BCR/ABL positive cells levels between 10 and 90%. In this subgroup, the cytogenetic tests were significantly higher [mean level 34% (95% CI 26, 45), p<0.001] than peripheral blood FISH and 23% (95% CI 13, 33, p<0.001) higher than bone marrow FISH. These observed differences may relate to the analysis of non-dividing cells in the FISH studies, including the assessment of Ph negative T lymphocytes in the peripheral blood, and need to be considered when monitoring patients by peripheral blood FISH studies alone. Figure Figure


Blood ◽  
2008 ◽  
Vol 112 (11) ◽  
pp. 3204-3204 ◽  
Author(s):  
Manuela Marega ◽  
Rocco Piazza ◽  
Iris Meneghetti ◽  
Sara Redaelli ◽  
Angela Mogavero ◽  
...  

Abstract The fusion protein BCR/ABL leads to chronic myeloid leukaemia (CML). The corresponding fusion gene is under the transcriptional control of BCR promoter. It is known that in CML progenitors the ability to block myeloid differentiation is directly related to BCR/ABL levels. These observations open new questions about BCR/ABL and BCR expression control. However, up to date only few studies have been focused on the characterization of the BCR promoter, so little is known about the transcriptional regulation of this gene. We studied BCR expression in sorted myeloid precursors in healthy donors (HD) and in CML patients in Chronic Phase (CP) and Blast Crisis (BC). CML samples were also analyzed for BCR/ABL. The expression level was analyzed by Real Time PCR normalized against GUS as housekeeping gene, in haematopoietic stem cells (HSCs defined as CD34+/CD38−/Thy+/−), common myeloid and granulocyte-monocyte progenitors (CMPs and GMPs, respectively defined as CD34+/CD38+/IL−3Ralo/CD45RA− and CD34+/CD38+/IL−3Ralo/CD45RA+,) sorted by Fluorescence Activated Cell Sorting (FACS). Preliminarly, we analyzed the BCR and BCR/ABL mRNA halflife. We performed a RNA stability assay using Actinomycin D in the K562 cell line and in CP and BC samples: the halflife of both genes were comparable thus excluding major differences in RNA stability. Then, we analyzed BCR levels in healthy donors. A statistically significant BCR downregulation was noted during myeloid maturation in HD (HSCs [0.815±0.27SD] vs CMPs [0.176±0.1] and vs GMPs [0.167±0.17], p=0.0079 in both cases). The same analysis performed in CP patients showed that both BCR and BCR/ABL were downregulated upon committement to differentiation (BCR: HSCs [0.326±0.24] vs CMPs [0.0899±0.054], p=0.0078, and vs GMPs [0.0277±0.07], p=0.0008; BCR/ABL: HSCs [2.99±1.76] vs CMPs [0.781±0.41], p=0.0005 and vs GMPs [0.304±0.46], p=0.028). However, while BCR levels were lower in CML samples compared to HD (HSC samples [0.815±0.27 vs 0.326±0.24]: p=0.0120), probably due to haploinsufficiency, BCR/ABL values were higher than BCR ones, when compared to CML (HSCs: p=0.0020) and even to HD samples (HSCs: p=0.0074). These data indicate that in CML a potent upregulation of BCR/ABL compared to BCR is present, probably caused by a selective mechanism acting on BCR/ABL. In a limited set of BC samples (4 patients), the decrease of BCR and BCR/ABL was less evident and did not reach statistical significance (BCR: HSCs 0.339±0.235; CMPs: 0.135±0.12; GMPs: 0.126±0.06; BCR/ABL: HSCs: 8.58±5.78; CMPs: 5.55±7.39; GMPs: 3.36±2.61); thus as already indicated by Jamieson and colleagues (NEJM, 351:657, 2004), in BC the downregulation of BCR/ABL during maturation is impaired. Moreover, we detected a tendency for higher expression of BCR/ABL in BC than CP in all the subpopulations under study, which reached statistical significance only in GMPs (HSCs [8.58±5.78 BC vs 2.99±1.76 CP]: p=0.1483; CMPs [5.55±7.39 BC vs 0.781±0.41 CP]: p=0.1483; GMPs [3.36±2.61 BC vs 0.304±0.46 CP]: p=0.028); BCR was upregulated only in GMPs (HSCs [BC 0.339±0.235 vs 0.326±0.24 CP]: p=0.9399; CMPs [0.135±0.12 vs 0.0899±0.054]: p=0.4818; GMPs [0.126±0.06 vs 0.0277±0.07]: p=0.0755). In conclusion, BCR is physiologically downregulated during myeloid maturation, and this regulation is conserved in CP-CML, not only for BCR but also for BCR/ABL. In BC-CML, this mechanism of regulation seems to be impaired for BCR/ABL and possibly for BCR too. In addition, a potent upregulation of BCR/ABL compared to BCR is present in all stages of CML, probably caused by a selective mechanism acting on BCR/ABL.


2021 ◽  
Vol 11 (10) ◽  
pp. 4334
Author(s):  
Guadalupe O. Gutiérrez-Esparza ◽  
Tania A. Ramírez-delReal ◽  
Mireya Martínez-García ◽  
Oscar Infante Infante Vázquez ◽  
Maite Vallejo ◽  
...  

The exponential increase of metabolic syndrome and its association with the risk impact of morbidity and mortality has propitiated the development of tools to diagnose this syndrome early. This work presents a model that is based on prognostic variables to classify Mexicans with metabolic syndrome without blood screening applying machine and deep learning. The data that were used in this study contain health parameters related to anthropometric measurements, dietary information, smoking habit, alcohol consumption, quality of sleep, and physical activity from 2289 participants of the Mexico City Tlalpan 2020 cohort. We use accuracy, balanced accuracy, positive predictive value, and negative predictive value criteria to evaluate the performance and validate different models. The models were separated by gender due to the shared features and different habits. Finally, the highest performance model in women found that the most relevant features were: waist circumference, age, body mass index, waist to height ratio, height, sleepy manner that is associated with snoring, dietary habits related with coffee, cola soda, whole milk, and Oaxaca cheese and diastolic and systolic blood pressure. Men’s features were similar to women’s; the variations were in dietary habits, especially in relation to coffee, cola soda, flavored sweetened water, and corn tortilla consumption. The positive predictive value obtained was 84.7% for women and 92.29% for men. With these models, we offer a tool that supports Mexicans to prevent metabolic syndrome by gender; it also lays the foundation for monitoring the patient and recommending change habits.


2009 ◽  
Vol 17 (1-2) ◽  
pp. 13-18
Author(s):  
Beena Patel ◽  
Pina Trivedi ◽  
Manisha Brahmbhatt ◽  
Sarju Gajjar ◽  
Ramesh Iyer ◽  
...  

Background: To evaluate prognostic effect of submicroscopic deletions involving breakage and fusion points of the derivative chromosome 9 and 22 in chronic myeloid leukemia in untreated patients and their follow up samples to correlate with disease outcome. Methods: The study included 78 pretreatment (PT) samples from CML patients and 90 follow-up samples, classified as complete responders (CR, n=33), nonresponders (NR, n =54), and partial responder (PR, n=3) depending on the treatment status of the follow-up samples. Karyotype analysis was performed on metaphases obtained through short term cultures of bone marrow and blood. Detection of BCR-ABL fusion gene was performed using dual color dual fusion (D-FISH) translocation probes. Results: BCR-ABL fusion gene detection by D-FISH showed ABL-BCR deletion on derivative 9 in 47.8% of nonresponders which was higher as compared to pretreatment (11%). Mix D-FISH signal pattern was found in around 20% of pretreatment and non-responder samples. Average interval from chronic phase to blast crisis and accelerated phase was respectively 3.5 and 18 months and accelerated to blast crisis was 16.5 months from the time of diagnosis. The follow-up duration of 31 patients responded to therapy was significantly higher (p=0.0001) as compared to 45 patients who did not respond to therapy. Variant D-FISH signal pattern was seen at the time of diagnosis in patient who responded to therapy as well as those patients who did not respond to therapy. Conclusion: This is the first study from India reporting deletion in ABL, BCR, or ABL-BCR on derivative 9 did not correlate with response to therapy.


2018 ◽  
Vol 9 (5) ◽  
pp. 172
Author(s):  
Abdalla Abdelrahman Ahmed Elnour ◽  
Mahdi H.A. Abdalla

Breakpoint cluster region-abelson (BCR-ABL) leukemic fusion gene types in chronic myeloid leukemia (CML) correlate with the disease clinical course and outcome. There are variations in the reports of previous studies about the frequencies and distribution of BCR-ABL transcripts in chronic myelogenous leukaemia among Sudanese patients. This research aims to determine the frequencies of BCR-ABL fusion transcript variants in Sudan. One hundred (informed consent) Philadelphia positive chronic myeloid leukaemia patients, in chronic phase, were enrolled in this study. EDTA anticoagulated peripheral blood samples were collected from each participant, RNA was extracted from mononuclear cells by (TRIzol) reagent. BCR-ABL transcripts were detected by qRT-PCR technique with specific primers forP190 and P210 BCR-ABL transcript variants. The typical p210 BCR-ABL transcripts (b3a2 or b2a2) were detected in all patients (100%) the b3a2 transcript was detected in 96/100 (96%) and the b2a2 transcript was detected in 4/100 (4%).co-expression of p210/p190 (b2a3/e1a2) was detected in 6/100 (6%). p190 variant was not detected independently. 


2020 ◽  
Vol 2020 ◽  
pp. 1-7
Author(s):  
Amaya Aura Linda ◽  
Florence Kyallo ◽  
Judith K. Okoth ◽  
Peter Kahenya ◽  
Anselimo Makokha ◽  
...  

More than half of the morbidity and mortality cases among children in Kenya are as a result of micronutrient deficiencies (MNDs). Food fortification is considered by the Government of Kenya as a feasible strategy for addressing MNDs. Worldwide, fortification has been proven to be effective since it does not require any change in dietary habits. Success of large-scale food fortification however may depend on consumer awareness of the fortification benefits. A cross-sectional study was conducted in 13 counties to collect information on fortification awareness using structured questionnaires. 1435 respondents were selected using the Lot Quality Assurance Sampling method. Data were analyzed using Stata version 14.0 and statistical significance p<0.05. The study participants were described using descriptive statistics. The association of sociodemographic characteristics and awareness of fortification was performed using binary logistic regression analysis. The median age of the study participants was 35 years. Only 28% of the respondents were aware of the term “fortification.” Of the respondents, about 27% heard of food fortification through radio. Vernacular radio emerged as the most preferred channel for communicating fortification information among 24.9% of the respondents. Although awareness of vitamins (32%) and minerals (1.5%) was limited, most (76%) respondents reported of existence of health risks for lacking micronutrients. Awareness of food fortification was significantly associated with respondents’ occupation (p< 0.001), household size (p=0.012), education levels (p<0.001), and age (p=0.025). There is need for a wider use of broadcast media sources to modify information and education materials to promote fortification awareness among Kenyan consumers.


2005 ◽  
Vol 162 (1) ◽  
pp. 50-56 ◽  
Author(s):  
Carmen de Torres ◽  
Teresa M. Cardesa ◽  
Sandra Rodríguez-Perales ◽  
Juan C. Cigudosa ◽  
Jaume Mora

Blood ◽  
2008 ◽  
Vol 112 (11) ◽  
pp. 4246-4246
Author(s):  
Xuemei Sun ◽  
Junhao Chen ◽  
Pengjun Jiang ◽  
Xuejun Zhu

Abstract Assay of phosphotyrosine levels using flow cytometry has been used to identify patients with chronic myelogenous leukemia (CML) positive for the Bcr-Abl fusion gene. We hypothesized that clinical monitoring could identify treatment response through reductions in intra-granulocyte phosphotyrosine. Initially, we studied cell lines FDC-P1 and HL60 (Bcr-Abl–negative) and FDrv210 and K562 (Bcr-Abl–positive) with our technique. A fluorescein isothiocyanate-conjugated monoclonal antibody was used along with fluorescence-conjugated microspheres for reference (ratio of sample fluorescence: bead fluorescence=relative fluorescence unit [RFU]). Samples from 20 controls and 32 patients undergoing treatment were analyzed using the same method. Bcr-Abl status for each patient was confirmed using fluorescent in situ hybridization (FISH) or polymerase chain reaction gene amplification (PCR). Testing of cell lines consistently produced expected results. Patient values were found to be significantly higher than control values (P&lt;0.001) and values for patients with advanced disease were significantly higher than for patients with chronic-phase disease (P&lt; 0.05). Results of clinical monitoring were consistent with results from PCR. Two patients who received allogeneic stem cell transplantation had molecular remission confirmed by PCR and had a marked decrease in RFU value (from 62 to 5 and from 131 to 23). No such fluorescence change was observed in patients who achieved clinical remission. Flow cytometric analysis of phosphotyrosine levels is a reliable and convenient adjuvant technique for diagnosis of Bcr-Abl–positive leukemias and shows promise for serial evaluation of patients undergoing treatment.


Blood ◽  
2008 ◽  
Vol 112 (11) ◽  
pp. 4243-4243
Author(s):  
Song Zhang ◽  
Qingfeng Du ◽  
Hongqian Zhu ◽  
Rong Li ◽  
Zhi Liu ◽  
...  

Abstract Imatinib has impressive response rates and good tolerability quickly led to its adoption as frontline therapy for all patients with chronic-phase CML (chronic myeloid leukemia), but the therapeutic effect of imatinib is poor in the blast crisis, and imatinib resistance has become a major problem in CML. The possible mechanisms of imatinib resistance include the amplification of BCR-ABL fusion gene and its expression increase, the point mutant of BCR-ABL kinase domain and the effects of other tyrosine kinases such as Src, Hck and Lyn and so on. However, the second-generation tyrosine kinase inhibitors (such as nilotinib and dasatinib), which were developed to overcome imatinib resistance resulting from the point mutant or the activation of other tyrosine kinases, even can not prevent all patients with CML progression to drug resistance. So there would be the other potential factor in imatinib resistance. Our previous studies generated a new imatinib-resistant BCR/ABL-positive cell line, K562-R. The 50% inhibitory concentration of imatinib was 15-fold higher in K562-R than in the wild-type K562. The expression of RhoA gene is up-regulated in K562-R by microarray analyses. RhoA, a small GTPase (24KD), has been found overexpression in breast, colon, head and neck squamous cell carcinoma, bladderand testicular cancer, lung and gastric cancer. It plays an important role in the initiation as well as the progression of human cancer, but the potential role of RhoA related to imatinib resistance has yet been unknown. In this study, we firstly detect the biologic characteristic of K562-R cells with RhoA down-expression by RNA interference. When K562-R cells were transfected with 150nM siRNA-RhoA for 48 hours, the percentage of apoptotic K562-R cells is respectively 12.82% by AnnexinV-PI assay and 9.0% by Hoechst 33258 staining and both have significant increase, cell cycle analysis found significant G0/G1 arrest, the expression of CD29 increase and that of CD71 and GPA have no difference. Secondly, The K562-R cells were treated with three selective inhibitors, including PD98059 (Ras/MAPK inhibitor), LY294002 (PI3K/AKT inhibitor) and AG490(JAK/STAT inhibitor) for 2,4 and 8 hours and the expression of RhoA were analyzed by Western-Blotting. The expression of RhoA is arrested in the K562-R cells treated with PD98059 and AG490 and no different with LY294002. These results indicate that RhoA would be an important target in the down-stream of multi-signal pathways related to imatinib resistance and the potential function of RhoA in imatinib resistance involve in increasing of cell proliferation, resistance to cell apoptosis and changes of cell adhesion.


2011 ◽  
Vol 14 (12) ◽  
pp. 2176-2184 ◽  
Author(s):  
Bárbara da Silva Nalin de Souza ◽  
Maria Luiza Garcia Rosa ◽  
Jocemir R Lugon ◽  
Edna Massae Yokoo ◽  
Evandro Tinoco Mesquita ◽  
...  

AbstractObjectiveTo estimate dietary habits and other factors associated with inadequate blood pressure (BP) control in hypertensive patients adherent to antihypertensive drug treatment assisted by a Brazilian Family Doctor Program (FDP).DesignA cross-sectional study.SettingFDP units, Niterói, Rio de Janeiro, Brazil.SubjectsWe included data from both male and female participants aged ≥20 years. Participants completed a standardized questionnaire containing questions related to demographics, socio-economic factors, comorbidities and lifestyle, as well as a validated FFQ and eleven additional qualitative questions to investigate dietary habits. Food items were divided into sixteen groups. Medical consultations were performed, BP measurements were taken, blood and urine samples were assessed and anthropometric and nutritional status was evaluated.ResultsIndividuals with inadequate BP control presented higher BMI values (prevalence ratio (PR) = 1·027, 95 % CI 1·009, 1·045) and also consumed more meat (PR = 1·091, 95 % CI 1·022, 1·165), which are potentially modifiable variables. Higher levels of serum creatinine (PR = 1·894, 95 % CI 1·241, 2·892) were also associated with inadequate BP control, as were skin colour (white). After inclusion of the Na excretion index, which is an indirect measure of salt intake, a slight decrease was observed in the PR for meat, which resulted in loss of statistical significance.ConclusionsThe results indicate that salt consumption, skin colour, BMI and serum creatinine are associated with inadequate BP control.


Sign in / Sign up

Export Citation Format

Share Document